• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CONCENTRIC MEDICAL TREVO XP PROVUE RETRIEVER 4X20; CATHETER, THROMBUS RETRIEVER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CONCENTRIC MEDICAL TREVO XP PROVUE RETRIEVER 4X20; CATHETER, THROMBUS RETRIEVER Back to Search Results
Catalog Number 90182
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Infarction, Cerebral (1771); Embolus (1830); Neurological Deficit/Dysfunction (1982)
Event Date 07/04/2016
Event Type  Injury  
Manufacturer Narrative
The subject device is not available.
 
Event Description
The patient underwent thrombectomy procedure of the right m1 and m2 segments of the middle cerebral artery (mca).Post procedure the patient achieved a tici of 2b and at 24 hours the patient was assessed having a nihss of 15.The patient was discharged to inpatient rehab approximately 24 days post procedure with a nihss of 12 and a modified ranquin scale (mrs) of 4.Embolization to new (ent) was not observed by the study facility post procedure; however, further review performed by independent lab facility indicated that ent occurred.The affected territory was not disclosed and no adverse events associated with the ent were reported.No further information is available.
 
Manufacturer Narrative
Outcomes attributed to ae - updated to reflect medical management.Executive summary - updated to reflect ent location along with patient stroke and neurological deficit due to new stroke expiration and manufacturing dates - updated.The device history record (dhr) review confirmed that the device met all material, assembly and performance specifications.The subject device was not returned; therefore, physical as well as a functional evaluation could not be performed.However, embolus and neurological deficit are known risks associated with endovascular procedures and are noted as such in the device direction for use (dfu).Therefore, an assignable cause of anticipated procedural complications was assigned to this event.
 
Event Description
The patient underwent thrombectomy procedure of the right m1 and m2 segments of the middle cerebral artery (mca).Post procedure the patient achieved a tici of 2b and at 24 hours the patient was assessed having a nihss of 15.The patient was discharged to inpatient rehab approximately 24 days post procedure with a nihss of 12 and a modified ranquin scale (mrs) of 4.Review performed by independent lab facility indicated that an ent occurred.The study facility confirmed the core lab finding indicating that after the first pass of the retriever in the mca, a right anterior cerebral artery (r-aca) clot developed.The patient experienced a moderate aca stroke that was treated with medical management.The relationship of the patient's ent was assessed as related to the procedure and device.It was reported that approximately 10 months post the index procedure the patient has left side severe weakness, dysarthria and a nihss of 10-12.No further information is available.
 
Manufacturer Narrative
Evaluation summary corrected to reflect stroke (infarction, cerebral).The device history record (dhr) review confirmed that the device met all material, assembly and performance specifications.The subject device was not returned; therefore, physical as well as a functional evaluation could not be performed.However, embolus, stroke and neurological deficit are known risks associated with endovascular procedures and are noted as such in the device direction for use (dfu).Therefore, an assignable cause of anticipated procedural complications was assigned to this event.
 
Event Description
The patient underwent thrombectomy procedure of the right m1 and m2 segments of the middle cerebral artery (mca).Post procedure the patient achieved a tici of 2b and at 24 hours the patient was assessed having a nihss of 15.The patient was discharged to inpatient rehab approximately 24 days post procedure with a nihss of 12 and a modified ranquin scale (mrs) of 4.Review performed by independent lab facility indicated that an ent occurred.The study facility confirmed the core lab finding indicating that after the first pass of the retriever in the mca, a right anterior cerebral artery (r-aca) clot developed.The patient experienced a moderate aca stroke that was treated with medical management.The relationship of the patient's ent was assessed as related to the procedure and device.It was reported that approximately 10 months post the index procedure the patient has left side severe weakness, dysarthria and a nihss of 10-12.No further information is available.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TREVO XP PROVUE RETRIEVER 4X20
Type of Device
CATHETER, THROMBUS RETRIEVER
Manufacturer (Section D)
CONCENTRIC MEDICAL
301 east evelyn
mountain view CA 94041
Manufacturer (Section G)
CONCENTRIC MEDICAL
301 east evelyn
mountain view CA 94041
Manufacturer Contact
tara lopez
301 east evelyn
mountain view, CA 94041
6509382100
MDR Report Key6601284
MDR Text Key76290622
Report Number0002954917-2017-00048
Device Sequence Number1
Product Code NRY
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K132641
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type study
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 08/09/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date03/28/2018
Device Catalogue Number90182
Device Lot Number39967
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 05/02/2017
Initial Date FDA Received05/31/2017
Supplement Dates Manufacturer Received07/16/2017
07/16/2017
Supplement Dates FDA Received08/03/2017
08/09/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured03/30/2016
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other; Required Intervention;
Patient Age34 YR
-
-